Editorial Snapshot: Preventing the publication of fraudulent research
- Details
- Published: 2022/04/20
Just recently, on January 12, 2022, the co-owner of a clinical research site, Olga Torres, pleaded guilty to a charge of obstructing an FDA investigation into falsified clinical trial data. Her firm, Unlimited Medical Research, was among several hired to conduct a clinical trial to assess the safety and efficacy of an asthma medication in children.